SLC38A5 and neoplasm: The in vitro experiments described above suggested the potent tumor-suppressive activity of niclosamide by the ability of the drug to induce oxidative stress and iron-induced ferroptosis via the blockade of the expression and function of SLC38A5 and SLC7A11.